user-circle-o search facebook linkedin2 twitter document-download info

Arexvy and Abrysvo: The RSV Vaccines and their Impact on Global Health

vaccine researchers RSV Virus

Introduction to the RSV Virus

As the world continues to grapple with the challenges of the pandemic, it’s easy to overlook other significant health threats. The Respiratory Syncytial Virus (RSV), a common respiratory infection, can cause severe symptoms in vulnerable patients. However, recent developments in vaccine creation have provided a solution.

In this article, we will explore what the RSV vaccine is, how it’s affecting the world, its storage and usage requirements, and what medical facilities need to do to prepare in the days ahead.


What is the RSV Vaccine?

For decades, the medical community has been striving to develop an effective RSV vaccine. This endeavor has faced numerous challenges, including the virus’s ability to mutate rapidly. However, in recent years, researchers have made significant strides in understanding RSV’s behavior and developing vaccines to combat it.

A groundbreaking development occurred with the FDA’s recent approval of the first RSV vaccine for adults aged 60 and above. Arexvy by GSK was approved in early 2023 followed by Pfizer’s Abrysvo RSV vaccine. Both vaccines are designed to protect older adults against severe RSV infections.


How the RSV Vaccine is Affecting the World

The impact of the RSV vaccine is far-reaching, as it addresses a long-standing gap in our defense against respiratory infections. The RSV vaccine offers far-reaching impacts globally, including the below benefits:


Protecting Vulnerable Populations

RSV disproportionately affects infants, young children, and older adults, often leading to hospitalizations. The vaccine’s approval for older adults seeks to reduce the severity of RSV infections in this demographic, potentially saving lives.

Reducing Healthcare Burden

RSV infections strain healthcare systems annually, especially during the winter months. The availability of an effective vaccine can help alleviate this burden by preventing severe cases and hospitalizations.

Combined Efforts with COVID-19 and Flu Vaccines

RSV vaccines are expected to be available in the same timeframe as COVID-19 and flu vaccines.1 This co-administration can streamline vaccination efforts and provide protection against multiple respiratory illnesses.


Storage and Usage of RSV Vaccines

The proper storage and administration of RSV vaccines are critical to their effectiveness. Here’s what you need to know about storage guidelines for the RSV vaccine:


Storage Temperature of RSV Vaccines

According to the CDC, RSV vaccines should be stored at refrigerated temperatures of 2°C to 8°C.2 Medical facilities should use dedicated vaccine storage units that can maintain these conditions to ensure freshness and potency.

Both GSK’s Arexvy vaccine and Pfizer’s RSV vaccine should be refrigerated in original packaging components and maintain a 2°C to 8°C temperature range. Neither of these vaccines should be stored in frozen conditions and must be discarded in the case of accidental freezing.

Administering the Vaccine

Healthcare providers must be trained in the correct administration of the RSV vaccine. Proper preparation and reconstitution techniques are crucial for its effectiveness.

Patient Education

Patients, especially older adults, should receive clear information about the RSV vaccination, including its benefits and risks.


Preparing Medical Facilities for RSV Vaccine Storage

Medical facilities play a pivotal role in the successful rollout of the RSV vaccine. Here are steps they can take to ensure proper vaccine storage:


Invest in Suitable Storage Facilities: Allocate funds to purchase and maintain specialized vaccine storage units that can maintain the required temperature range.

Provide Staff Training: Train healthcare staff in vaccine handling, storage, and administration protocols to prevent errors and ensure patient safety.

Monitor Vaccine Inventory: Implement a robust inventory tracking system to prevent vaccine spoilage or waste.

Collaborate with Health Allies: Collaborate with local health departments and community organizations to educate patients about the RSV vaccine and provide convenient access to RSV vaccines.


Wrapping Up 

The approval of the RSV vaccine for older adults marks a significant milestone in the battle against respiratory infections. As the world continues to navigate the complexities of the pandemic, the introduction of effective vaccines against other respiratory illnesses like RSV is a positive step forward. By understanding what the RSV vaccine is, its global impact, and necessary preparations, we can work together towards a healthier future for all.


American Biotech Supply offers a full range of medical grade vaccine cold storage to deliver peak freshness and efficacy.

Explore today.


Please contact us to discuss the best possible solutions for your refrigeration requirements and needs

Contact Us via web


via email:

Customer Service